SMILES string
C[C@H](C1=CC=CC=C1)NC2=C3C(NC(C4=CC=C(CN5CCN(CC)CC5)C=C4)=C3)=NC=N2
InChI
1S/C27H32N6/c1-3-32-13-15-33(16-14-32)18-21-9-11-23(12-10-21)25-17-24-26(28-19-29-27(24)31-25)30-20(2)22-7-5-4-6-8-22/h4-12,17,19-20H,3,13-16,18H2,1-2H3,(H2,28,29,30,31)/t20-/m1/s1
InChI key
OONFNUWBHFSNBT-HXUWFJFHSA-N
assay
≥98% (HPLC)
form
powder
color
white to beige
solubility
H2O: 10 mg/mL, clear
storage temp.
−20°C
Gene Information
human ... EGFR(1956), ERBB2(2064), FLT1(2321), KDR(3791)
Biochem/physiol Actions
AEE788 is an orally available and potent dual family of human EGFR and VEGFR receptor tyrosine kinase inhibitor that exhibits potent antitumor and antiangiogenic activity.
AEE788 is an orally available and potent dual family of human EGFR and VEGFR receptor tyrosine kinase inhibitor.
存储类别
13 - Non Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
法规信息
新产品
此项目有
Rintu Thomas et al.
International journal of molecular sciences, 20(10) (2019-05-28)
Inhibiting the tyrosine kinase activity of epidermal growth factor receptor (EGFR) using small molecule tyrosine kinase inhibitors (TKIs) is often ineffective in treating cancers harboring wild-type EGFR (wt-EGFR). TKIs are known to cause dimerization of EGFR without altering its expression
我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持